首页 > 最新文献

JMIR Cancer最新文献

英文 中文
Engagement With a Relaxation and Mindfulness Mobile App Among People With Cancer: Exploratory Analysis of Use Data and Self-Reports From a Randomized Controlled Trial. 癌症患者使用放松和正念手机应用的情况:随机对照试验中使用数据和自我报告的探索性分析。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-31 DOI: 10.2196/52386
Sonja Schläpfer, Fabian Schneider, Prabhakaran Santhanam, Manuela Eicher, Tobias Kowatsch, Claudia M Witt, Jürgen Barth

Background: Mobile health (mHealth) apps offer unique opportunities to support self-care and behavior change, but poor user engagement limits their effectiveness. This is particularly true for fully automated mHealth apps without any human support. Human support in mHealth apps is associated with better engagement but at the cost of reduced scalability.

Objective: This work aimed to (1) describe the theory-informed development of a fully automated relaxation and mindfulness app to reduce distress in people with cancer (CanRelax app 2.0), (2) describe engagement with the app on multiple levels within a fully automated randomized controlled trial over 10 weeks, and (3) examine whether engagement was related to user characteristics.

Methods: The CanRelax app 2.0 was developed in iterative processes involving input from people with cancer and relevant experts. The app includes evidence-based relaxation exercises, personalized weekly coaching sessions with a rule-based conversational agent, 39 self-enactable behavior change techniques, a self-monitoring dashboard with gamification elements, highly tailored reminder notifications, an educational video clip, and personalized in-app letters. For the larger study, German-speaking adults diagnosed with cancer within the last 5 years were recruited via the web in Switzerland, Austria, and Germany. Engagement was analyzed in a sample of 100 study participants with multiple measures on a micro level (completed coaching sessions, relaxation exercises practiced with the app, and feedback on the app) and a macro level (relaxation exercises practiced without the app and self-efficacy toward self-set weekly relaxation goals).

Results: In week 10, a total of 62% (62/100) of the participants were actively using the CanRelax app 2.0. No associations were identified between engagement and level of distress at baseline, sex assigned at birth, educational attainment, or age. At the micro level, 71.88% (3520/4897) of all relaxation exercises and 714 coaching sessions were completed in the app, and all participants who provided feedback (52/100, 52%) expressed positive app experiences. At the macro level, 28.12% (1377/4897) of relaxation exercises were completed without the app, and participants' self-efficacy remained stable at a high level. At the same time, participants raised their weekly relaxation goals, which indicates a potential relative increase in self-efficacy.

Conclusions: The CanRelax app 2.0 achieved promising engagement even though it provided no human support. Fully automated social components might have compensated for the lack of human involvement and should be investigated further. More than one-quarter (1377/4897, 28.12%) of all relaxation exercises were practiced without the app, highlighting the importance of assessing engagement on multiple levels.

背景:移动医疗(mHealth)应用程序为支持自我保健和行为改变提供了独特的机会,但用户参与度低限制了其有效性。对于没有任何人工支持的全自动移动医疗应用程序来说尤其如此。移动医疗应用程序中的人工支持可提高用户参与度,但其代价是降低可扩展性:这项工作旨在:(1)描述以理论为依据开发的全自动放松和正念应用程序(CanRelax 应用程序 2.0),以减轻癌症患者的痛苦;(2)描述在为期 10 周的全自动随机对照试验中多层次的参与情况;(3)研究参与情况是否与用户特征有关:CanRelax 应用程序 2.0 是在癌症患者和相关专家的参与下反复开发的。该应用程序包括循证放松练习、每周与基于规则的对话代理进行的个性化辅导课程、39 种可自我演绎的行为改变技巧、带有游戏元素的自我监控仪表板、高度定制的提醒通知、教育视频剪辑以及个性化的应用程序内信件。在这项大型研究中,瑞士、奥地利和德国通过网络招募了在过去 5 年中被诊断患有癌症的德语成年人。研究人员对 100 名研究参与者的参与情况进行了抽样分析,从微观层面(完成辅导课程、使用应用程序进行放松练习和应用程序反馈)和宏观层面(不使用应用程序进行放松练习和实现自我设定的每周放松目标的自我效能)进行了多重测量:在第 10 周,共有 62% 的参与者(62/100)积极使用 CanRelax 应用程序 2.0。参与度与基线时的痛苦程度、出生时的性别、教育程度或年龄之间没有关联。在微观层面上,71.88%(3520/4897)的参与者完成了应用程序中的所有放松练习和 714 次辅导课程,所有提供反馈的参与者(52/100,52%)都表达了对应用程序的积极体验。在宏观层面上,28.12%(1377/4897)的放松练习是在没有使用应用程序的情况下完成的,参与者的自我效能感稳定在较高水平。与此同时,参与者提高了每周的放松目标,这表明自我效能感可能会相对提高:CanRelax 2.0 应用程序在没有人工支持的情况下,仍取得了良好的参与效果。全自动社交组件可能会弥补人工参与的不足,应进一步研究。超过四分之一(1377/4897,28.12%)的放松练习是在没有使用该应用程序的情况下进行的,这凸显了从多个层面评估参与度的重要性。
{"title":"Engagement With a Relaxation and Mindfulness Mobile App Among People With Cancer: Exploratory Analysis of Use Data and Self-Reports From a Randomized Controlled Trial.","authors":"Sonja Schläpfer, Fabian Schneider, Prabhakaran Santhanam, Manuela Eicher, Tobias Kowatsch, Claudia M Witt, Jürgen Barth","doi":"10.2196/52386","DOIUrl":"10.2196/52386","url":null,"abstract":"<p><strong>Background: </strong>Mobile health (mHealth) apps offer unique opportunities to support self-care and behavior change, but poor user engagement limits their effectiveness. This is particularly true for fully automated mHealth apps without any human support. Human support in mHealth apps is associated with better engagement but at the cost of reduced scalability.</p><p><strong>Objective: </strong>This work aimed to (1) describe the theory-informed development of a fully automated relaxation and mindfulness app to reduce distress in people with cancer (CanRelax app 2.0), (2) describe engagement with the app on multiple levels within a fully automated randomized controlled trial over 10 weeks, and (3) examine whether engagement was related to user characteristics.</p><p><strong>Methods: </strong>The CanRelax app 2.0 was developed in iterative processes involving input from people with cancer and relevant experts. The app includes evidence-based relaxation exercises, personalized weekly coaching sessions with a rule-based conversational agent, 39 self-enactable behavior change techniques, a self-monitoring dashboard with gamification elements, highly tailored reminder notifications, an educational video clip, and personalized in-app letters. For the larger study, German-speaking adults diagnosed with cancer within the last 5 years were recruited via the web in Switzerland, Austria, and Germany. Engagement was analyzed in a sample of 100 study participants with multiple measures on a micro level (completed coaching sessions, relaxation exercises practiced with the app, and feedback on the app) and a macro level (relaxation exercises practiced without the app and self-efficacy toward self-set weekly relaxation goals).</p><p><strong>Results: </strong>In week 10, a total of 62% (62/100) of the participants were actively using the CanRelax app 2.0. No associations were identified between engagement and level of distress at baseline, sex assigned at birth, educational attainment, or age. At the micro level, 71.88% (3520/4897) of all relaxation exercises and 714 coaching sessions were completed in the app, and all participants who provided feedback (52/100, 52%) expressed positive app experiences. At the macro level, 28.12% (1377/4897) of relaxation exercises were completed without the app, and participants' self-efficacy remained stable at a high level. At the same time, participants raised their weekly relaxation goals, which indicates a potential relative increase in self-efficacy.</p><p><strong>Conclusions: </strong>The CanRelax app 2.0 achieved promising engagement even though it provided no human support. Fully automated social components might have compensated for the lack of human involvement and should be investigated further. More than one-quarter (1377/4897, 28.12%) of all relaxation exercises were practiced without the app, highlighting the importance of assessing engagement on multiple levels.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e52386"},"PeriodicalIF":2.8,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11179041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Quality of Cancer-Related WeChat Public Accounts: Cross-Sectional Study. 评估癌症相关微信公众账号的质量:横断面研究。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-30 DOI: 10.2196/52156
Peng Pan, Changhua Yu, Tao Li, Tingting Dai, Hanhan Tian, Yaozu Xiong, Jie Lv, Xiaochu Hu, Weidong Ma, Wenda Yin

Background: WeChat (Tencent) is one of the most important information sources for Chinese people. Relevantly, various health-related data are constantly transmitted among WeChat users. WeChat public accounts (WPAs) for health are rapidly emerging. Health-related WeChat public accounts have a significant impact on public health. Because of the rise in web-based health-seeking behavior, the general public has grown accustomed to obtaining cancer information from WPAs. Although WPAs make it easy for people to obtain health information, the quality of the information is questionable.

Objective: This study aims to assess the quality and suitability of cancer-related WeChat public accounts (CWPAs).

Methods: The survey was conducted from February 1 to 28, 2023. Based on the WPA monthly list provided by Qingbo Big Data, 28 CWPAs in the WeChat communication index were selected as the survey sample. Quality assessment of the included CWPAs was performed using the HONcode instrument. Furthermore, suitability was measured by using the Suitability Assessment of Materials. A total of 2 researchers conducted the evaluations independently.

Results: Of the 28 CWPAs, 12 (43%) were academic and 16 (57%) were commercial. No statistical difference was found regarding the HONcode scores between the 2 groups (P=.96). The quality of the academic and commercial CWPAs evaluated using the HONcode instrument demonstrated mean scores of 5.58 (SD 2.02) and 5.63 (SD 2.16), respectively, corresponding to a moderate class. All CWPAs' compliance with the HONcode principles was unsatisfactory. A statistically significant difference between the 2 groups was observed in the Suitability Assessment of Materials scores (P=.04). The commercial WPAs reached an overall 55.1% (SD 5.5%) score versus the 50.2% (SD 6.4%) score reached by academic WPAs. The suitability of academic and commercial CWPAs was considered adequate.

Conclusions: This study revealed that CWPAs are not sufficiently credible. WPA owners must endeavor to create reliable health websites using approved tools such as the HONcode criteria. However, it is necessary to educate the public about the evaluation tools of health websites to assess their credibility before using the provided content. In addition, improving readability will allow the public to read and understand the content.

背景介绍微信(腾讯)是中国人最重要的信息来源之一。与此相关的是,各种与健康相关的数据不断在微信用户间传播。健康类微信公众账号(WPA)正在迅速崛起。与健康相关的微信公众账号对公众健康有着重要影响。由于网络健康搜索行为的兴起,公众已习惯于从 WPA 获取癌症信息。虽然微信公众平台使人们可以轻松获取健康信息,但其信息质量却值得怀疑:本研究旨在评估癌症相关微信公众账号(CWPA)的质量和适用性:调查时间为 2023 年 2 月 1 日至 28 日。调查时间为 2023 年 2 月 1 日至 28 日。根据清博大数据提供的 WPA 月度榜单,选取微信传播指数中的 28 个 CWPA 作为调查样本。使用 HONcode 工具对纳入的 CWPA 进行了质量评估。此外,还使用 "材料适宜性评估 "对适宜性进行了测量。共有两名研究人员独立进行了评估:结果:在 28 个 CWPA 中,12 个(43%)是学术性的,16 个(57%)是商业性的。两组的 HONcode 分数没有统计学差异(P=.96)。使用 HONcode 工具对学术和商业 CWPA 的质量进行评估后发现,其平均得分分别为 5.58(标准差 2.02)和 5.63(标准差 2.16),属于中等水平。所有 CWPA 对 HONcode 原则的遵守情况均不令人满意。在 "材料适用性评估 "得分方面,两组之间的差异具有统计学意义(P=0.04)。商业 WPA 的总体得分率为 55.1%(标准差为 5.5%),而学术 WPA 的得分率为 50.2%(标准差为 6.4%)。学术和商业 CWPA 的适用性被认为是充分的:这项研究表明,CWPA 的可信度不够。WPA 所有者必须努力使用经认可的工具(如 HONcode 标准)创建可靠的健康网站。不过,有必要教育公众了解健康网站的评估工具,以便在使用所提供的内容之前评估其可信度。此外,提高可读性将使公众能够阅读和理解内容。
{"title":"Evaluating the Quality of Cancer-Related WeChat Public Accounts: Cross-Sectional Study.","authors":"Peng Pan, Changhua Yu, Tao Li, Tingting Dai, Hanhan Tian, Yaozu Xiong, Jie Lv, Xiaochu Hu, Weidong Ma, Wenda Yin","doi":"10.2196/52156","DOIUrl":"10.2196/52156","url":null,"abstract":"<p><strong>Background: </strong>WeChat (Tencent) is one of the most important information sources for Chinese people. Relevantly, various health-related data are constantly transmitted among WeChat users. WeChat public accounts (WPAs) for health are rapidly emerging. Health-related WeChat public accounts have a significant impact on public health. Because of the rise in web-based health-seeking behavior, the general public has grown accustomed to obtaining cancer information from WPAs. Although WPAs make it easy for people to obtain health information, the quality of the information is questionable.</p><p><strong>Objective: </strong>This study aims to assess the quality and suitability of cancer-related WeChat public accounts (CWPAs).</p><p><strong>Methods: </strong>The survey was conducted from February 1 to 28, 2023. Based on the WPA monthly list provided by Qingbo Big Data, 28 CWPAs in the WeChat communication index were selected as the survey sample. Quality assessment of the included CWPAs was performed using the HONcode instrument. Furthermore, suitability was measured by using the Suitability Assessment of Materials. A total of 2 researchers conducted the evaluations independently.</p><p><strong>Results: </strong>Of the 28 CWPAs, 12 (43%) were academic and 16 (57%) were commercial. No statistical difference was found regarding the HONcode scores between the 2 groups (P=.96). The quality of the academic and commercial CWPAs evaluated using the HONcode instrument demonstrated mean scores of 5.58 (SD 2.02) and 5.63 (SD 2.16), respectively, corresponding to a moderate class. All CWPAs' compliance with the HONcode principles was unsatisfactory. A statistically significant difference between the 2 groups was observed in the Suitability Assessment of Materials scores (P=.04). The commercial WPAs reached an overall 55.1% (SD 5.5%) score versus the 50.2% (SD 6.4%) score reached by academic WPAs. The suitability of academic and commercial CWPAs was considered adequate.</p><p><strong>Conclusions: </strong>This study revealed that CWPAs are not sufficiently credible. WPA owners must endeavor to create reliable health websites using approved tools such as the HONcode criteria. However, it is necessary to educate the public about the evaluation tools of health websites to assess their credibility before using the provided content. In addition, improving readability will allow the public to read and understand the content.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e52156"},"PeriodicalIF":2.8,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141176136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Introduction to the OutSMART Cancer Serious Game: Current and Future Directions. OutSMART 癌症严肃游戏简介:当前和未来方向。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-29 DOI: 10.2196/56168
Olufunmilola Abraham, Tyler J McCarthy

Given that cancer is a challenging disease that plagues millions of individuals of all age groups and socioeconomic statuses globally, developmentally appropriate education is often lacking for young people, particularly adolescents. Increasing cancer awareness and prevention education among adolescents using innovative strategies, such as game-based learning, is critical in reducing the burden of this disease. Adolescents are understudied in the field of cancer prevention and control, yet vulnerable as they tackle creating life-long health behavior patterns. Targeting cancer prevention education for adolescents has the potential to support long-term healthy behavior and reduce their risk of cancer. This paper provides an overview of the Collaborative Research on MEdication use and family health (CRoME) Lab's novel game-based cancer prevention education tool. OutSMART Cancer is an innovative, novel educational intervention in the form of a serious game. Serious games are educational tools that seek to impart knowledge and improve behaviors in their players. This game covers information related to breast cancer, colon cancer, and lung cancer. This viewpoint is a summary of the developmental process for the OutSMART Cancer game. We describe in detail the work preceding initial game development, the current version of the game, future directions for the game, and its educational potential. The long-term goal of OutSMART Cancer is to improve cancer awareness and knowledge regarding prevention behaviors in adolescents and support a lifetime of health and wellness.

癌症是一种具有挑战性的疾病,困扰着全球各年龄段和社会经济地位的数百万人,而针对年轻人,尤其是青少年的适合其发展的教育却往往缺乏。利用创新策略(如游戏式学习)提高青少年对癌症的认识并加强预防教育,对于减轻这一疾病的负担至关重要。青少年在癌症预防和控制领域的研究不足,但他们在建立终身健康行为模式时却很脆弱。针对青少年的癌症预防教育有可能支持他们的长期健康行为,降低他们罹患癌症的风险。本文概述了 "药物使用与家庭健康合作研究(CRoME)实验室 "基于游戏的新型癌症预防教育工具。OutSMART Cancer 是一种以严肃游戏为形式的创新型教育干预措施。严肃游戏是一种教育工具,旨在向玩家传授知识和改善行为。这款游戏涵盖了与乳腺癌、结肠癌和肺癌相关的信息。本视角总结了 OutSMART 癌症游戏的开发过程。我们详细描述了最初游戏开发之前的工作、当前的游戏版本、游戏的未来发展方向及其教育潜力。OutSMART Cancer 的长期目标是提高青少年对癌症的认识和有关预防行为的知识,并为其一生的健康和幸福提供支持。
{"title":"An Introduction to the OutSMART Cancer Serious Game: Current and Future Directions.","authors":"Olufunmilola Abraham, Tyler J McCarthy","doi":"10.2196/56168","DOIUrl":"10.2196/56168","url":null,"abstract":"<p><p>Given that cancer is a challenging disease that plagues millions of individuals of all age groups and socioeconomic statuses globally, developmentally appropriate education is often lacking for young people, particularly adolescents. Increasing cancer awareness and prevention education among adolescents using innovative strategies, such as game-based learning, is critical in reducing the burden of this disease. Adolescents are understudied in the field of cancer prevention and control, yet vulnerable as they tackle creating life-long health behavior patterns. Targeting cancer prevention education for adolescents has the potential to support long-term healthy behavior and reduce their risk of cancer. This paper provides an overview of the Collaborative Research on MEdication use and family health (CRoME) Lab's novel game-based cancer prevention education tool. OutSMART Cancer is an innovative, novel educational intervention in the form of a serious game. Serious games are educational tools that seek to impart knowledge and improve behaviors in their players. This game covers information related to breast cancer, colon cancer, and lung cancer. This viewpoint is a summary of the developmental process for the OutSMART Cancer game. We describe in detail the work preceding initial game development, the current version of the game, future directions for the game, and its educational potential. The long-term goal of OutSMART Cancer is to improve cancer awareness and knowledge regarding prevention behaviors in adolescents and support a lifetime of health and wellness.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e56168"},"PeriodicalIF":2.8,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Notification! You May Have Cancer." Could Smartphones and Wearables Help Detect Cancer Early? "通知!您可能患有癌症"。智能手机和可穿戴设备能否帮助早期检测癌症?
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-20 DOI: 10.2196/52577
Suzanne E Scott, Matthew J Thompson

This viewpoint paper considers the authors' perspectives on the potential role of smartphones, wearables, and other technologies in the diagnosis of cancer. We believe that these technologies could be valuable additions in the pursuit of early cancer diagnosis, as they offer solutions to the timely detection of signals or symptoms and monitoring of subtle changes in behavior that may otherwise be missed. In addition to signal detection, technologies could assist symptom interpretation and guide and facilitate access to health care. This paper aims to provide an overview of the scientific rationale as to why these technologies could be valuable for early cancer detection, as well as outline the next steps for research and development to drive investigation into the potential for smartphones and wearables in this context and optimize implementation. We draw attention to potential barriers to successful implementation, including the difficulty of the development of signals and sensors with sufficient utility and accuracy through robust research with the target group. There are regulatory challenges; the potential for innovations to exacerbate inequalities; and questions surrounding acceptability, uptake, and correct use by the intended target group and health care practitioners. Finally, there is potential for unintended consequences on individuals and health care services including unnecessary anxiety, increased symptom burden, overinvestigation, and inappropriate use of health care resources.

这篇观点论文从作者的角度探讨了智能手机、可穿戴设备和其他技术在癌症诊断中的潜在作用。我们认为,这些技术可以成为早期癌症诊断的重要补充,因为它们为及时发现信号或症状以及监测行为的细微变化提供了解决方案,否则可能会被遗漏。除了信号检测外,技术还可以帮助解释症状,指导和促进医疗服务的获取。本文旨在概述这些技术对早期癌症检测具有重要价值的科学依据,并概述下一步的研发工作,以推动研究智能手机和可穿戴设备在这方面的潜力并优化实施。我们提请注意成功实施的潜在障碍,包括通过对目标群体进行深入研究,开发具有足够实用性和准确性的信号和传感器的难度。此外,还存在监管方面的挑战;创新可能会加剧不平等现象;预期目标群体和医疗保健从业人员的接受能力、吸收能力和正确使用能力也存在问题。最后,还有可能对个人和医疗服务造成意想不到的后果,包括不必要的焦虑、症状负担加重、过度调查和医疗资源的不当使用。
{"title":"\"Notification! You May Have Cancer.\" Could Smartphones and Wearables Help Detect Cancer Early?","authors":"Suzanne E Scott, Matthew J Thompson","doi":"10.2196/52577","DOIUrl":"10.2196/52577","url":null,"abstract":"<p><p>This viewpoint paper considers the authors' perspectives on the potential role of smartphones, wearables, and other technologies in the diagnosis of cancer. We believe that these technologies could be valuable additions in the pursuit of early cancer diagnosis, as they offer solutions to the timely detection of signals or symptoms and monitoring of subtle changes in behavior that may otherwise be missed. In addition to signal detection, technologies could assist symptom interpretation and guide and facilitate access to health care. This paper aims to provide an overview of the scientific rationale as to why these technologies could be valuable for early cancer detection, as well as outline the next steps for research and development to drive investigation into the potential for smartphones and wearables in this context and optimize implementation. We draw attention to potential barriers to successful implementation, including the difficulty of the development of signals and sensors with sufficient utility and accuracy through robust research with the target group. There are regulatory challenges; the potential for innovations to exacerbate inequalities; and questions surrounding acceptability, uptake, and correct use by the intended target group and health care practitioners. Finally, there is potential for unintended consequences on individuals and health care services including unnecessary anxiety, increased symptom burden, overinvestigation, and inappropriate use of health care resources.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e52577"},"PeriodicalIF":2.8,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141064800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differing Content and Language Based on Poster-Patient Relationships on the Chinese Social Media Platform Weibo: Text Classification, Sentiment Analysis, and Topic Modeling of Posts on Breast Cancer. 中国社交媒体平台微博上基于发帖人与患者关系的不同内容和语言:关于乳腺癌帖子的文本分类、情感分析和主题建模。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-09 DOI: 10.2196/51332
Zhouqing Zhang, Kongmeng Liew, Roeline Kuijer, Wan Jou She, Shuntaro Yada, Shoko Wakamiya, Eiji Aramaki
<p><strong>Background: </strong>Breast cancer affects the lives of not only those diagnosed but also the people around them. Many of those affected share their experiences on social media. However, these narratives may differ according to who the poster is and what their relationship with the patient is; a patient posting about their experiences may post different content from someone whose friends or family has breast cancer. Weibo is 1 of the most popular social media platforms in China, and breast cancer-related posts are frequently found there.</p><p><strong>Objective: </strong>With the goal of understanding the different experiences of those affected by breast cancer in China, we aimed to explore how content and language used in relevant posts differ according to who the poster is and what their relationship with the patient is and whether there are differences in emotional expression and topic content if the patient is the poster themselves or a friend, family member, relative, or acquaintance.</p><p><strong>Methods: </strong>We used Weibo as a resource to examine how posts differ according to the different poster-patient relationships. We collected a total of 10,322 relevant Weibo posts. Using a 2-step analysis method, we fine-tuned 2 Chinese Robustly Optimized Bidirectional Encoder Representations from Transformers (BERT) Pretraining Approach models on this data set with annotated poster-patient relationships. These models were lined in sequence, first a binary classifier (no_patient or patient) and then a multiclass classifier (post_user, family_members, friends_relatives, acquaintances, heard_relation), to classify poster-patient relationships. Next, we used the Linguistic Inquiry and Word Count lexicon to conduct sentiment analysis from 5 emotion categories (positive and negative emotions, anger, sadness, and anxiety), followed by topic modeling (BERTopic).</p><p><strong>Results: </strong>Our binary model (F<sub>1</sub>-score=0.92) and multiclass model (F<sub>1</sub>-score=0.83) were largely able to classify poster-patient relationships accurately. Subsequent sentiment analysis showed significant differences in emotion categories across all poster-patient relationships. Notably, negative emotions and anger were higher for the "no_patient" class, but sadness and anxiety were higher for the "family_members" class. Focusing on the top 30 topics, we also noted that topics on fears and anger toward cancer were higher in the "no_patient" class, but topics on cancer treatment were higher in the "family_members" class.</p><p><strong>Conclusions: </strong>Chinese users post different types of content, depending on the poster- poster-patient relationships. If the patient is family, posts are sadder and more anxious but also contain more content on treatments. However, if no patient is detected, posts show higher levels of anger. We think that these may stem from rants from posters, which may help with emotion regulation and gathering social supp
背景:乳腺癌不仅影响着确诊者的生活,也影响着周围人的生活。许多患者在社交媒体上分享他们的经历。然而,这些叙述可能会因发布者的身份及其与患者的关系而有所不同;患者在发布自己的经历时可能会与朋友或家人患有乳腺癌的人发布不同的内容。微博是中国最受欢迎的社交媒体平台之一,与乳腺癌相关的帖子在微博上经常可见:为了了解中国乳腺癌患者的不同经历,我们旨在探索相关帖子的内容和语言在发帖人是谁及其与患者的关系不同的情况下有何不同,如果患者是发帖人本人还是朋友、家人、亲戚或熟人,情感表达和话题内容是否存在差异:我们以微博为资源,研究了发帖者与患者之间不同关系下的发帖差异。我们共收集了 10,322 条相关微博。我们采用两步分析法,在这一数据集上微调了 2 个中文的 "从变换器中稳健优化的双向编码器表征(BERT)预训练法 "模型,并注释了贴主与患者的关系。这些模型按顺序排列,首先是二分类器(无病人或病人),然后是多分类器(post_user、family_members、friends_relatives、acquaintances、heard_relation),对海报与病人的关系进行分类。接下来,我们使用语言学探究和字数词典从 5 个情绪类别(积极和消极情绪、愤怒、悲伤和焦虑)进行情感分析,然后进行主题建模(BERTopic):我们的二元模型(F1-score=0.92)和多类模型(F1-score=0.83)在很大程度上能够准确分类海报与患者之间的关系。随后的情感分析表明,在所有的海报-患者关系中,情感类别存在显著差异。值得注意的是,"无患者 "类别的负面情绪和愤怒情绪较高,而 "家庭成员 "类别的悲伤和焦虑情绪较高。在前 30 个主题中,我们还注意到 "非患者 "类别中关于对癌症的恐惧和愤怒的主题较多,而 "家庭成员 "类别中关于癌症治疗的主题较多:结论:中国用户会根据发帖人与发帖人之间的关系发布不同类型的内容。如果患者是家属,帖子会更悲伤、更焦虑,但也包含更多关于治疗的内容。然而,如果没有发现患者,帖子则显示出更高的愤怒程度。我们认为这可能源于发帖人的咆哮,这可能有助于情绪调节和收集社会支持。
{"title":"Differing Content and Language Based on Poster-Patient Relationships on the Chinese Social Media Platform Weibo: Text Classification, Sentiment Analysis, and Topic Modeling of Posts on Breast Cancer.","authors":"Zhouqing Zhang, Kongmeng Liew, Roeline Kuijer, Wan Jou She, Shuntaro Yada, Shoko Wakamiya, Eiji Aramaki","doi":"10.2196/51332","DOIUrl":"10.2196/51332","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Breast cancer affects the lives of not only those diagnosed but also the people around them. Many of those affected share their experiences on social media. However, these narratives may differ according to who the poster is and what their relationship with the patient is; a patient posting about their experiences may post different content from someone whose friends or family has breast cancer. Weibo is 1 of the most popular social media platforms in China, and breast cancer-related posts are frequently found there.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;With the goal of understanding the different experiences of those affected by breast cancer in China, we aimed to explore how content and language used in relevant posts differ according to who the poster is and what their relationship with the patient is and whether there are differences in emotional expression and topic content if the patient is the poster themselves or a friend, family member, relative, or acquaintance.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We used Weibo as a resource to examine how posts differ according to the different poster-patient relationships. We collected a total of 10,322 relevant Weibo posts. Using a 2-step analysis method, we fine-tuned 2 Chinese Robustly Optimized Bidirectional Encoder Representations from Transformers (BERT) Pretraining Approach models on this data set with annotated poster-patient relationships. These models were lined in sequence, first a binary classifier (no_patient or patient) and then a multiclass classifier (post_user, family_members, friends_relatives, acquaintances, heard_relation), to classify poster-patient relationships. Next, we used the Linguistic Inquiry and Word Count lexicon to conduct sentiment analysis from 5 emotion categories (positive and negative emotions, anger, sadness, and anxiety), followed by topic modeling (BERTopic).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Our binary model (F&lt;sub&gt;1&lt;/sub&gt;-score=0.92) and multiclass model (F&lt;sub&gt;1&lt;/sub&gt;-score=0.83) were largely able to classify poster-patient relationships accurately. Subsequent sentiment analysis showed significant differences in emotion categories across all poster-patient relationships. Notably, negative emotions and anger were higher for the \"no_patient\" class, but sadness and anxiety were higher for the \"family_members\" class. Focusing on the top 30 topics, we also noted that topics on fears and anger toward cancer were higher in the \"no_patient\" class, but topics on cancer treatment were higher in the \"family_members\" class.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Chinese users post different types of content, depending on the poster- poster-patient relationships. If the patient is family, posts are sadder and more anxious but also contain more content on treatments. However, if no patient is detected, posts show higher levels of anger. We think that these may stem from rants from posters, which may help with emotion regulation and gathering social supp","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e51332"},"PeriodicalIF":2.8,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11117131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in Trust in Cancer Information Sources by Perceptions of Social Media Health Mis- and Disinformation and by Race and Ethnicity Among Adults in the United States: Cross-Sectional Study. 美国成年人对社交媒体健康误导和虚假信息的看法以及种族和民族对癌症信息来源信任度的差异:横断面研究。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-08 DOI: 10.2196/54162
Jim P Stimpson, Sungchul Park, Sandi L Pruitt, Alexander N Ortega
<p><strong>Background: </strong>Mis- and disinformation on social media have become widespread, which can lead to a lack of trust in health information sources and, in turn, lead to negative health outcomes. Moreover, the effect of mis- and disinformation on trust in information sources may vary by racial and ethnic minoritized populations.</p><p><strong>Objective: </strong>We evaluated how trust in multiple sources of cancer information varied by perceptions of health mis- and disinformation on social media and by race and ethnicity.</p><p><strong>Methods: </strong>Cross-sectional, nationally representative survey data from noninstitutionalized adults in the United States from the 2022 Health Information National Trends Survey 6 (HINTS 6) were analyzed (N=4137). The dependent variable measured the level of trust in cancer information sources. The independent variables were perceptions about health mis- and disinformation on social media and race and ethnicity. Multivariable logistic regression models were adjusted for survey weight and design, age, birth gender, race and ethnicity, marital status, urban/rural designation, education, employment status, feelings about household income, frequency of social media visits, and personal and family history of cancer. We also tested the interaction effect between perceptions of social media health mis- and disinformation and participants' self-reported race and ethnicity.</p><p><strong>Results: </strong>Perception of "a lot of" health mis- and disinformation on social media, relative to perception of "less than a lot," was associated with a lower likelihood of high levels of trusting cancer information from government health agencies (odds ratio [OR] 0.60, 95% CI 0.47-0.77), family or friends (OR 0.56, 95% CI 0.44-0.71), charitable organizations (OR 0.78, 95% CI 0.63-0.96), and religious organizations and leaders (OR 0.64, 95% CI 0.52-0.79). Among White participants, those who perceived a lot of health mis- and disinformation on social media were less likely to have high trust in cancer information from government health agencies (margin=61%, 95% CI 57%-66%) and family or friends (margin=49%, 95% CI 43%-55%) compared to those who perceived less than a lot of health mis- and disinformation on social media. Among Black participants, those who perceived a lot of health mis- and disinformation on social media were less likely to have high trust in cancer information from religious organizations and leaders (margin=20%, 95% CI 10%-30%) compared to participants who perceived no or a little health mis- and disinformation on social media.</p><p><strong>Conclusions: </strong>Certain sources of cancer information may need enhanced support against the threat of mis- and disinformation, such as government health agencies, charitable organizations, religious organizations and leaders, and family or friends. Moreover, interventions should partner with racial and ethnically minoritized populations that are more likely
背景:社交媒体上的错误信息和虚假信息已变得十分普遍,这会导致人们对健康信息来源缺乏信任,进而导致不良的健康后果。此外,误导和虚假信息对信息来源信任度的影响可能因种族和少数族裔人群而异:我们评估了对多种癌症信息来源的信任度如何因对社交媒体上的健康误导和虚假信息的看法以及种族和民族而有所不同:我们分析了 2022 年第六次全国健康信息趋势调查(HINTS 6)中具有全国代表性的美国非住院成年人的横断面调查数据(N=4137)。因变量衡量的是对癌症信息来源的信任程度。自变量是对社交媒体上的健康误导和虚假信息的看法以及种族和民族。多变量逻辑回归模型对调查的权重和设计、年龄、出生性别、种族和民族、婚姻状况、城市/农村划分、教育程度、就业状况、对家庭收入的感受、访问社交媒体的频率以及个人和家族癌症病史进行了调整。我们还测试了对社交媒体健康误导和虚假信息的看法与参与者自我报告的种族和民族之间的交互效应:结果:认为社交媒体上存在 "大量 "健康误导和虚假信息的人与认为 "少于大量 "的人相比,更有可能高度信任来自政府卫生机构(几率比 [OR] 0.60,95% CI 0.47-0.77)、家人或朋友(OR 0.56,95% CI 0.44-0.71)、慈善组织(OR 0.78,95% CI 0.63-0.96)以及宗教组织和领袖(OR 0.64,95% CI 0.52-0.79)的癌症信息。在白人参与者中,认为社交媒体上存在大量健康误导和虚假信息的人与认为社交媒体上存在较少健康误导和虚假信息的人相比,不太可能高度信任来自政府卫生机构(margin=61%,95% CI 57%-66%)和家人或朋友(margin=49%,95% CI 43%-55%)的癌症信息。在黑人参与者中,认为社交媒体上存在大量健康误导和虚假信息的人与认为社交媒体上没有或只有少量健康误导和虚假信息的人相比,不太可能高度信任来自宗教组织和领袖的癌症信息(margin=20%,95% CI 10%-30% ):某些癌症信息来源可能需要加强支持,以应对误导和虚假信息的威胁,如政府卫生机构、慈善组织、宗教组织和领袖以及家人或朋友。此外,干预措施应与种族和民族上的少数群体合作,因为他们更有可能对与社交媒体上的误导和虚假信息相关的某些癌症信息来源信任度较低。
{"title":"Variation in Trust in Cancer Information Sources by Perceptions of Social Media Health Mis- and Disinformation and by Race and Ethnicity Among Adults in the United States: Cross-Sectional Study.","authors":"Jim P Stimpson, Sungchul Park, Sandi L Pruitt, Alexander N Ortega","doi":"10.2196/54162","DOIUrl":"10.2196/54162","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Mis- and disinformation on social media have become widespread, which can lead to a lack of trust in health information sources and, in turn, lead to negative health outcomes. Moreover, the effect of mis- and disinformation on trust in information sources may vary by racial and ethnic minoritized populations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;We evaluated how trust in multiple sources of cancer information varied by perceptions of health mis- and disinformation on social media and by race and ethnicity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Cross-sectional, nationally representative survey data from noninstitutionalized adults in the United States from the 2022 Health Information National Trends Survey 6 (HINTS 6) were analyzed (N=4137). The dependent variable measured the level of trust in cancer information sources. The independent variables were perceptions about health mis- and disinformation on social media and race and ethnicity. Multivariable logistic regression models were adjusted for survey weight and design, age, birth gender, race and ethnicity, marital status, urban/rural designation, education, employment status, feelings about household income, frequency of social media visits, and personal and family history of cancer. We also tested the interaction effect between perceptions of social media health mis- and disinformation and participants' self-reported race and ethnicity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Perception of \"a lot of\" health mis- and disinformation on social media, relative to perception of \"less than a lot,\" was associated with a lower likelihood of high levels of trusting cancer information from government health agencies (odds ratio [OR] 0.60, 95% CI 0.47-0.77), family or friends (OR 0.56, 95% CI 0.44-0.71), charitable organizations (OR 0.78, 95% CI 0.63-0.96), and religious organizations and leaders (OR 0.64, 95% CI 0.52-0.79). Among White participants, those who perceived a lot of health mis- and disinformation on social media were less likely to have high trust in cancer information from government health agencies (margin=61%, 95% CI 57%-66%) and family or friends (margin=49%, 95% CI 43%-55%) compared to those who perceived less than a lot of health mis- and disinformation on social media. Among Black participants, those who perceived a lot of health mis- and disinformation on social media were less likely to have high trust in cancer information from religious organizations and leaders (margin=20%, 95% CI 10%-30%) compared to participants who perceived no or a little health mis- and disinformation on social media.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Certain sources of cancer information may need enhanced support against the threat of mis- and disinformation, such as government health agencies, charitable organizations, religious organizations and leaders, and family or friends. Moreover, interventions should partner with racial and ethnically minoritized populations that are more likely ","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e54162"},"PeriodicalIF":2.8,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11112477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Cancer Communication on Twitter: Natural Language Processing and Qualitative Content Analysis. 推特上的儿科癌症传播:自然语言处理和定性内容分析。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-05-07 DOI: 10.2196/52061
Nancy Lau, Xin Zhao, Alison O'Daffer, Hannah Weissman, Krysta Barton

Background: During the COVID-19 pandemic, Twitter (recently rebranded as "X") was the most widely used social media platform with over 2 million cancer-related tweets. The increasing use of social media among patients and family members, providers, and organizations has allowed for novel methods of studying cancer communication.

Objective: This study aimed to examine pediatric cancer-related tweets to capture the experiences of patients and survivors of cancer, their caregivers, medical providers, and other stakeholders. We assessed the public sentiment and content of tweets related to pediatric cancer over a time period representative of the COVID-19 pandemic.

Methods: All English-language tweets related to pediatric cancer posted from December 11, 2019, to May 7, 2022, globally, were obtained using the Twitter application programming interface. Sentiment analyses were computed based on Bing, AFINN, and NRC lexicons. We conducted a supplemental nonlexicon-based sentiment analysis with ChatGPT (version 3.0) to validate our findings with a random subset of 150 tweets. We conducted a qualitative content analysis to manually code the content of a random subset of 800 tweets.

Results: A total of 161,135 unique tweets related to pediatric cancer were identified. Sentiment analyses showed that there were more positive words than negative words. Via the Bing lexicon, the most common positive words were support, love, amazing, heaven, and happy, and the most common negative words were grief, risk, hard, abuse, and miss. Via the NRC lexicon, most tweets were categorized under sentiment types of positive, trust, and joy. Overall positive sentiment was consistent across lexicons and confirmed with supplemental ChatGPT (version 3.0) analysis. Percent agreement between raters for qualitative coding was 91%, and the top 10 codes were awareness, personal experiences, research, caregiver experiences, patient experiences, policy and the law, treatment, end of life, pharmaceuticals and drugs, and survivorship. Qualitative content analysis showed that Twitter users commonly used the social media platform to promote public awareness of pediatric cancer and to share personal experiences with pediatric cancer from the perspective of patients or survivors and their caregivers. Twitter was frequently used for health knowledge dissemination of research findings and federal policies that support treatment and affordable medical care.

Conclusions: Twitter may serve as an effective means for researchers to examine pediatric cancer communication and public sentiment around the globe. Despite the public mental health crisis during the COVID-19 pandemic, overall sentiments of pediatric cancer-related tweets were positive. Content of pediatric cancer tweets focused on health and treatment information, social support, and raising awareness of pediatric cancer.

背景:在 COVID-19 大流行期间,Twitter(最近更名为 "X")是使用最广泛的社交媒体平台,与癌症相关的推文超过 200 万条。患者和家庭成员、医疗机构和组织越来越多地使用社交媒体,这为研究癌症传播提供了新方法:本研究旨在研究儿科癌症相关推文,以捕捉癌症患者和幸存者、其护理人员、医疗服务提供者和其他利益相关者的经历。我们评估了 COVID-19 大流行期间与儿科癌症相关的推文的公众情绪和内容:我们使用 Twitter 应用程序接口获取了从 2019 年 12 月 11 日到 2022 年 5 月 7 日全球范围内发布的所有与儿科癌症相关的英文推文。根据 Bing、AFINN 和 NRC 词库进行了情感分析。我们使用 ChatGPT(3.0 版)进行了基于非词库的补充情感分析,通过 150 条推文的随机子集验证了我们的研究结果。我们还进行了定性内容分析,对 800 条推文的随机子集进行了人工编码:结果:共识别出 161,135 条与儿科癌症相关的独特推文。情感分析显示,正面词汇多于负面词汇。通过必应词典,最常见的正面词汇是支持、爱、神奇、天堂和快乐,最常见的负面词汇是悲伤、风险、艰难、虐待和错过。通过 NRC 词库,大多数推文被归类为积极、信任和快乐等情感类型。不同词库中的总体积极情绪是一致的,并通过 ChatGPT(3.0 版)补充分析得到了证实。定性编码的评分者之间的一致率为 91%,排名前 10 位的编码分别是意识、个人经历、研究、护理者经历、患者经历、政策和法律、治疗、生命终结、药品和药物以及幸存者。定性内容分析显示,Twitter 用户通常使用社交媒体平台提高公众对儿科癌症的认识,并从患者或幸存者及其照顾者的角度分享儿科癌症的个人经历。推特经常被用于传播健康知识,包括研究成果以及支持治疗和负担得起的医疗保健的联邦政策:Twitter可作为研究人员研究全球儿科癌症传播和公众情绪的有效手段。尽管在 COVID-19 大流行期间出现了公众心理健康危机,但儿科癌症相关推文的总体情绪是积极的。儿科癌症推文的内容主要集中在健康和治疗信息、社会支持以及提高人们对儿科癌症的认识等方面。
{"title":"Pediatric Cancer Communication on Twitter: Natural Language Processing and Qualitative Content Analysis.","authors":"Nancy Lau, Xin Zhao, Alison O'Daffer, Hannah Weissman, Krysta Barton","doi":"10.2196/52061","DOIUrl":"10.2196/52061","url":null,"abstract":"<p><strong>Background: </strong>During the COVID-19 pandemic, Twitter (recently rebranded as \"X\") was the most widely used social media platform with over 2 million cancer-related tweets. The increasing use of social media among patients and family members, providers, and organizations has allowed for novel methods of studying cancer communication.</p><p><strong>Objective: </strong>This study aimed to examine pediatric cancer-related tweets to capture the experiences of patients and survivors of cancer, their caregivers, medical providers, and other stakeholders. We assessed the public sentiment and content of tweets related to pediatric cancer over a time period representative of the COVID-19 pandemic.</p><p><strong>Methods: </strong>All English-language tweets related to pediatric cancer posted from December 11, 2019, to May 7, 2022, globally, were obtained using the Twitter application programming interface. Sentiment analyses were computed based on Bing, AFINN, and NRC lexicons. We conducted a supplemental nonlexicon-based sentiment analysis with ChatGPT (version 3.0) to validate our findings with a random subset of 150 tweets. We conducted a qualitative content analysis to manually code the content of a random subset of 800 tweets.</p><p><strong>Results: </strong>A total of 161,135 unique tweets related to pediatric cancer were identified. Sentiment analyses showed that there were more positive words than negative words. Via the Bing lexicon, the most common positive words were support, love, amazing, heaven, and happy, and the most common negative words were grief, risk, hard, abuse, and miss. Via the NRC lexicon, most tweets were categorized under sentiment types of positive, trust, and joy. Overall positive sentiment was consistent across lexicons and confirmed with supplemental ChatGPT (version 3.0) analysis. Percent agreement between raters for qualitative coding was 91%, and the top 10 codes were awareness, personal experiences, research, caregiver experiences, patient experiences, policy and the law, treatment, end of life, pharmaceuticals and drugs, and survivorship. Qualitative content analysis showed that Twitter users commonly used the social media platform to promote public awareness of pediatric cancer and to share personal experiences with pediatric cancer from the perspective of patients or survivors and their caregivers. Twitter was frequently used for health knowledge dissemination of research findings and federal policies that support treatment and affordable medical care.</p><p><strong>Conclusions: </strong>Twitter may serve as an effective means for researchers to examine pediatric cancer communication and public sentiment around the globe. Despite the public mental health crisis during the COVID-19 pandemic, overall sentiments of pediatric cancer-related tweets were positive. Content of pediatric cancer tweets focused on health and treatment information, social support, and raising awareness of pediatric cancer.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e52061"},"PeriodicalIF":2.8,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of Health IT for Cancer Screening in US Primary Care: Scoping Review. 在美国初级保健中实施用于癌症筛查的医疗信息技术:范围审查。
IF 3.3 Q2 ONCOLOGY Pub Date : 2024-04-30 DOI: 10.2196/49002
Constance Owens-Jasey, Jinying Chen, Ran Xu, Heather Angier, Amy G Huebschmann, Mayuko Ito Fukunaga, Krisda H Chaiyachati, Katharine A Rendle, Kim Robien, Lisa DiMartino, Daniel J Amante, Jamie M Faro, Maura M Kepper, Alex T Ramsey, Eric Bressman, Rachel Gold
<p><strong>Background: </strong>A substantial percentage of the US population is not up to date on guideline-recommended cancer screenings. Identifying interventions that effectively improve screening rates would enhance the delivery of such screening. Interventions involving health IT (HIT) show promise, but much remains unknown about how HIT is optimized to support cancer screening in primary care.</p><p><strong>Objective: </strong>This scoping review aims to identify (1) HIT-based interventions that effectively support guideline concordance in breast, cervical, and colorectal cancer screening provision and follow-up in the primary care setting and (2) barriers or facilitators to the implementation of effective HIT in this setting.</p><p><strong>Methods: </strong>Following scoping review guidelines, we searched MEDLINE, CINAHL Plus, Web of Science, and IEEE Xplore databases for US-based studies from 2015 to 2021 that featured HIT targeting breast, colorectal, and cervical cancer screening in primary care. Studies were dual screened using a review criteria checklist. Data extraction was guided by the following implementation science frameworks: the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework; the Expert Recommendations for Implementing Change taxonomy; and implementation strategy reporting domains. It was also guided by the Integrated Technology Implementation Model that incorporates theories of both implementation science and technology adoption. Reporting was guided by PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews).</p><p><strong>Results: </strong>A total of 101 studies met the inclusion criteria. Most studies (85/101, 84.2%) involved electronic health record-based HIT interventions. The most common HIT function was clinical decision support, primarily used for panel management or at the point of care. Most studies related to HIT targeting colorectal cancer screening (83/101, 82.2%), followed by studies related to breast cancer screening (28/101, 27.7%), and cervical cancer screening (19/101, 18.8%). Improvements in cancer screening were associated with HIT-based interventions in most studies (36/54, 67% of colorectal cancer-relevant studies; 9/14, 64% of breast cancer-relevant studies; and 7/10, 70% of cervical cancer-relevant studies). Most studies (79/101, 78.2%) reported on the reach of certain interventions, while 17.8% (18/101) of the included studies reported on the adoption or maintenance. Reported barriers and facilitators to HIT adoption primarily related to inner context factors of primary care settings (eg, staffing and organizational policies that support or hinder HIT adoption). Implementation strategies for HIT adoption were reported in 23.8% (24/101) of the included studies.</p><p><strong>Conclusions: </strong>There are substantial evidence gaps regarding the effectiveness of HIT-based interventions, especially those targeting guideline
背景:美国有相当大比例的人口没有接受指南推荐的最新癌症筛查。确定能够有效提高筛查率的干预措施将有助于加强此类筛查的实施。涉及医疗信息技术(HIT)的干预措施显示出了前景,但关于如何优化 HIT 以支持初级医疗中的癌症筛查,仍有许多未知之处:本范围界定综述旨在确定(1)基于 HIT 的干预措施,这些干预措施可有效支持初级医疗环境中乳腺癌、宫颈癌和结直肠癌筛查的提供和随访与指南保持一致;(2)在此环境中实施有效 HIT 的障碍或促进因素:根据范围界定综述指南,我们在 MEDLINE、CINAHL Plus、Web of Science 和 IEEE Xplore 数据库中检索了 2015 年至 2021 年期间以美国为基地的研究,这些研究以初级医疗中针对乳腺癌、结直肠癌和宫颈癌筛查的 HIT 为主题。研究采用审查标准清单进行双重筛选。数据提取以下列实施科学框架为指导:普及、效果、采用、实施和维护框架;实施变革的专家建议分类法;以及实施策略报告域。此外,还以综合技术实施模型为指导,该模型融合了实施科学和技术采用的理论。报告以 PRISMA-ScR(系统性综述和元分析的首选报告项目,范围综述的扩展)为指导:结果:共有 101 项研究符合纳入标准。大多数研究(85/101,84.2%)涉及基于电子健康记录的 HIT 干预。最常见的 HIT 功能是临床决策支持,主要用于小组管理或护理点。大多数与 HIT 相关的研究都针对大肠癌筛查(83/101,82.2%),其次是乳腺癌筛查(28/101,27.7%)和宫颈癌筛查(19/101,18.8%)。在大多数研究中,癌症筛查的改善与基于 HIT 的干预措施有关(36/54,占结直肠癌相关研究的 67%;9/14,占乳腺癌相关研究的 64%;7/10,占宫颈癌相关研究的 70%)。大多数研究(79/101,78.2%)报告了某些干预措施的覆盖范围,而纳入的研究中有 17.8%(18/101)报告了干预措施的采用或维持情况。所报告的采用 HIT 的障碍和促进因素主要与基层医疗机构的内在环境因素有关(例如,支持或阻碍采用 HIT 的人员配备和组织政策)。在纳入的研究中,23.8%(24/101)的研究报告了采用 HIT 的实施策略:结论:关于基于 HIT 的干预措施的有效性,尤其是针对初级保健中与指南一致的乳腺癌和结直肠癌筛查的干预措施的有效性,还存在很大的证据差距。至于如何促进采用已被证明能有效支持乳腺癌、结肠直肠癌或宫颈癌筛查的技术,人们所知就更少了。需要开展研究,以确保有效的基于 HIT 的干预措施的潜在益处公平地惠及不同的初级保健人群。
{"title":"Implementation of Health IT for Cancer Screening in US Primary Care: Scoping Review.","authors":"Constance Owens-Jasey, Jinying Chen, Ran Xu, Heather Angier, Amy G Huebschmann, Mayuko Ito Fukunaga, Krisda H Chaiyachati, Katharine A Rendle, Kim Robien, Lisa DiMartino, Daniel J Amante, Jamie M Faro, Maura M Kepper, Alex T Ramsey, Eric Bressman, Rachel Gold","doi":"10.2196/49002","DOIUrl":"10.2196/49002","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;A substantial percentage of the US population is not up to date on guideline-recommended cancer screenings. Identifying interventions that effectively improve screening rates would enhance the delivery of such screening. Interventions involving health IT (HIT) show promise, but much remains unknown about how HIT is optimized to support cancer screening in primary care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This scoping review aims to identify (1) HIT-based interventions that effectively support guideline concordance in breast, cervical, and colorectal cancer screening provision and follow-up in the primary care setting and (2) barriers or facilitators to the implementation of effective HIT in this setting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Following scoping review guidelines, we searched MEDLINE, CINAHL Plus, Web of Science, and IEEE Xplore databases for US-based studies from 2015 to 2021 that featured HIT targeting breast, colorectal, and cervical cancer screening in primary care. Studies were dual screened using a review criteria checklist. Data extraction was guided by the following implementation science frameworks: the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework; the Expert Recommendations for Implementing Change taxonomy; and implementation strategy reporting domains. It was also guided by the Integrated Technology Implementation Model that incorporates theories of both implementation science and technology adoption. Reporting was guided by PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 101 studies met the inclusion criteria. Most studies (85/101, 84.2%) involved electronic health record-based HIT interventions. The most common HIT function was clinical decision support, primarily used for panel management or at the point of care. Most studies related to HIT targeting colorectal cancer screening (83/101, 82.2%), followed by studies related to breast cancer screening (28/101, 27.7%), and cervical cancer screening (19/101, 18.8%). Improvements in cancer screening were associated with HIT-based interventions in most studies (36/54, 67% of colorectal cancer-relevant studies; 9/14, 64% of breast cancer-relevant studies; and 7/10, 70% of cervical cancer-relevant studies). Most studies (79/101, 78.2%) reported on the reach of certain interventions, while 17.8% (18/101) of the included studies reported on the adoption or maintenance. Reported barriers and facilitators to HIT adoption primarily related to inner context factors of primary care settings (eg, staffing and organizational policies that support or hinder HIT adoption). Implementation strategies for HIT adoption were reported in 23.8% (24/101) of the included studies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;There are substantial evidence gaps regarding the effectiveness of HIT-based interventions, especially those targeting guideline","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e49002"},"PeriodicalIF":3.3,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11094604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. HER2定向曲妥珠单抗生物仿制药Ogivri与赫赛汀治疗乳腺癌的真实世界症状和健康状况报告登记数据比较:患者电子报告结果的前瞻性观察研究 (OGIPRO)》。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-04-04 DOI: 10.2196/54178
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu
<p><strong>Background: </strong>Trastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using Herceptin as the reference product) in clinical trials. To our knowledge, there has been no real-world report of the side effects and quality of life (QoL) in patients treated with biosimilars using electronic patient-reported outcomes (ePROs).</p><p><strong>Objective: </strong>The primary objective of this prospective observational study (OGIPRO study) was to compare the ePRO data related to treatment side effects collected with the medidux app in patients with HER2-positive BC treated with the trastuzumab biosimilar Ogivri (prospective cohort) to those obtained from historical cohorts treated with Herceptin alone or combined with pertuzumab and/or chemotherapy (ClinicalTrials.gov NCT02004496 and NCT03578731).</p><p><strong>Methods: </strong>Patients were treated with Ogivri alone or combined with pertuzumab and/or chemotherapy and hormone therapy in (neo)adjuvant and palliative settings. Patients used the medidux app to dynamically record symptoms (according to the Common Terminology Criteria for Adverse Events [CTCAE]), well-being (according to the Eastern Cooperative Oncology Group Performance Status scale), QoL (using the EQ-5D-5L questionnaire), cognitive capabilities, and vital parameters over 6 weeks. The primary endpoint was the mean CTCAE score. Key secondary endpoints included the mean well-being score. Data of this prospective cohort were compared with those of the historical cohorts (n=38 patients; median age 51, range 31-78 years).</p><p><strong>Results: </strong>Overall, 53 female patients with a median age of 54 years (range 31-87 years) were enrolled in the OGIPRO study. The mean CTCAE score was analyzed in 50 patients with available data on symptoms, while the mean well-being score was evaluated in 52 patients with available data. The most common symptoms reported in both cohorts included fatigue, taste disorder, nausea, diarrhea, dry mucosa, joint discomfort, tingling, sleep disorder, headache, and appetite loss. Most patients experienced minimal (grade 0) or mild (grade 1) toxicities in both cohorts. The mean CTCAE score was comparable between the prospective and historical cohorts (29.0 and 30.3, respectively; mean difference -1.27, 95% CI -7.24 to 4.70; P=.68). Similarly, no significant difference was found for the mean well-being score between the groups treated with the trastuzumab biosimilar Ogivri and Herceptin (74.3 and 69.8, respectively; mean difference 4.45, 95% CI -3.53 to 12.44; P=.28).</p><p><strong>Conclusions: </strong>Treatment of patients with HER2-positive BC with the trastuzumab biosimilar Ogivri resulted in equivalent symptoms, adverse events, and well-being as found for patients treated with Herceptin as determined by ePRO data. Hence, in
背景:曲妥珠单抗对人类表皮生长因子受体 2(HER2)阳性乳腺癌(BC)的治疗产生了重大影响。在临床试验中,抗 HER2 生物仿制药(如 Ogivri)已证明与曲妥珠单抗(以赫赛汀为参照产品)具有安全性和临床等效性。据我们所知,目前还没有使用电子患者报告结果(ePROs)对接受生物仿制药治疗的患者的副作用和生活质量(QoL)进行真实世界报告:这项前瞻性观察研究(OGIPRO 研究)的主要目的是比较使用 medidux 应用程序收集的 HER2 阳性 BC 患者在接受曲妥珠单抗生物仿制药 Ogivri(前瞻性队列)治疗后的治疗副作用相关 ePRO 数据,以及从单独使用赫赛汀或联合百妥珠单抗和/或化疗的历史队列(ClinicalTrials.gov NCT02004496 和 NCT03578731)中获得的数据:在(新)辅助治疗和姑息治疗中,患者接受Ogivri单药或联合百妥珠单抗和/或化疗及激素治疗。患者使用 medidux 应用程序在 6 周内动态记录症状(根据不良事件通用术语标准 [CTCAE])、健康状况(根据东部合作肿瘤学组表现状态量表)、QoL(使用 EQ-5D-5L 问卷)、认知能力和生命参数。主要终点是 CTCAE 平均得分。主要次要终点包括平均健康评分。该前瞻性队列的数据与历史队列的数据进行了比较(38 名患者,中位年龄 51 岁,31-78 岁):共有 53 名女性患者参加了 OGIPRO 研究,中位年龄为 54 岁(31-87 岁不等)。对 50 名有症状数据的患者的平均 CTCAE 评分进行了分析,对 52 名有症状数据的患者的平均健康评分进行了评估。两组患者中最常见的症状包括疲劳、味觉障碍、恶心、腹泻、粘膜干燥、关节不适、刺痛、睡眠障碍、头痛和食欲不振。在两组患者中,大多数患者的毒性极小(0 级)或轻微(1 级)。前瞻性队列和历史性队列的平均 CTCAE 评分相当(分别为 29.0 分和 30.3 分;平均差异-1.27,95% CI -7.24 至 4.70;P=.68)。同样,使用曲妥珠单抗生物仿制药Ogivri和赫赛汀治疗的组别之间的平均幸福感得分也没有明显差异(分别为74.3和69.8;平均差异为4.45,95% CI为-3.53至12.44;P=.28):根据 ePRO 数据,使用曲妥珠单抗生物仿制药 Ogivri 治疗 HER2 阳性 BC 患者的症状、不良事件和健康状况与使用赫赛汀治疗的患者相当。因此,在研究类似治疗化合物的实际耐受性和结果时,将 ePRO 系统纳入研究和临床实践可提供可靠的信息:试验注册:ClinicalTrials.gov NCT05234021;https://clinicaltrials.gov/study/NCT05234021。
{"title":"Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes.","authors":"Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu","doi":"10.2196/54178","DOIUrl":"https://doi.org/10.2196/54178","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Trastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using Herceptin as the reference product) in clinical trials. To our knowledge, there has been no real-world report of the side effects and quality of life (QoL) in patients treated with biosimilars using electronic patient-reported outcomes (ePROs).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The primary objective of this prospective observational study (OGIPRO study) was to compare the ePRO data related to treatment side effects collected with the medidux app in patients with HER2-positive BC treated with the trastuzumab biosimilar Ogivri (prospective cohort) to those obtained from historical cohorts treated with Herceptin alone or combined with pertuzumab and/or chemotherapy (ClinicalTrials.gov NCT02004496 and NCT03578731).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients were treated with Ogivri alone or combined with pertuzumab and/or chemotherapy and hormone therapy in (neo)adjuvant and palliative settings. Patients used the medidux app to dynamically record symptoms (according to the Common Terminology Criteria for Adverse Events [CTCAE]), well-being (according to the Eastern Cooperative Oncology Group Performance Status scale), QoL (using the EQ-5D-5L questionnaire), cognitive capabilities, and vital parameters over 6 weeks. The primary endpoint was the mean CTCAE score. Key secondary endpoints included the mean well-being score. Data of this prospective cohort were compared with those of the historical cohorts (n=38 patients; median age 51, range 31-78 years).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Overall, 53 female patients with a median age of 54 years (range 31-87 years) were enrolled in the OGIPRO study. The mean CTCAE score was analyzed in 50 patients with available data on symptoms, while the mean well-being score was evaluated in 52 patients with available data. The most common symptoms reported in both cohorts included fatigue, taste disorder, nausea, diarrhea, dry mucosa, joint discomfort, tingling, sleep disorder, headache, and appetite loss. Most patients experienced minimal (grade 0) or mild (grade 1) toxicities in both cohorts. The mean CTCAE score was comparable between the prospective and historical cohorts (29.0 and 30.3, respectively; mean difference -1.27, 95% CI -7.24 to 4.70; P=.68). Similarly, no significant difference was found for the mean well-being score between the groups treated with the trastuzumab biosimilar Ogivri and Herceptin (74.3 and 69.8, respectively; mean difference 4.45, 95% CI -3.53 to 12.44; P=.28).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Treatment of patients with HER2-positive BC with the trastuzumab biosimilar Ogivri resulted in equivalent symptoms, adverse events, and well-being as found for patients treated with Herceptin as determined by ePRO data. Hence, in","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e54178"},"PeriodicalIF":2.8,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach. 共同设计、开发和评估用于改善癌症患者用药依从性的移动解决方案:设计科学研究方法。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-04-03 DOI: 10.2196/46979
Thu Ha Dang, Nilmini Wickramasinghe, Abdur Rahim Mohammad Forkan, Prem Prakash Jayaraman, Kate Burbury, Clare O'Callaghan, Ashley Whitechurch, Penelope Schofield

Background: Medication nonadherence negatively impacts the health outcomes of people with cancer as well as health care costs. Digital technologies present opportunities to address this health issue. However, there is limited evidence on how to develop digital interventions that meet the needs of people with cancer, are perceived as useful, and are potentially effective in improving medication adherence.

Objective: The objective of this study was to co-design, develop, and preliminarily evaluate an innovative mobile health solution called Safety and Adherence to Medication and Self-Care Advice in Oncology (SAMSON) to improve medication adherence among people with cancer.

Methods: Using the 4 cycles and 6 processes of design science research methodology, we co-designed and developed a medication adherence solution for people with cancer. First, we conducted a literature review on medication adherence in cancer and a systematic review of current interventions to address this issue. Behavioral science research was used to conceptualize the design features of SAMSON. Second, we conducted 2 design phases: prototype design and final feature design. Last, we conducted a mixed methods study on patients with hematological cancer over 6 weeks to evaluate the mobile solution.

Results: The developed mobile solution, consisting of a mobile app, a web portal, and a cloud-based database, includes 5 modules: medication reminder and acknowledgment, symptom assessment and management, reinforcement, patient profile, and reporting. The quantitative study (n=30) showed that SAMSON was easy to use (21/27, 78%). The app was engaging (18/27, 67%), informative, increased user interactions, and well organized (19/27, 70%). Most of the participants (21/27, 78%) commented that SAMSON's activities could help to improve their adherence to cancer treatments, and more than half of them (17/27, 63%) would recommend the app to their peers. The qualitative study (n=25) revealed that SAMSON was perceived as helpful in terms of reminding, supporting, and informing patients. Possible barriers to using SAMSON include the app glitches and users' technical inexperience. Further needs to refine the solution were also identified. Technical improvements and design enhancements will be incorporated into the subsequent iteration.

Conclusions: This study demonstrates the successful application of behavioral science research and design science research methodology to design and develop a mobile solution for patients with cancer to be more adherent. The study also highlights the importance of applying rigorous methodologies in developing effective and patient-centered digital intervention solutions.

背景:不遵医嘱用药会对癌症患者的健康状况和医疗成本产生负面影响。数字技术为解决这一健康问题提供了机会。然而,关于如何开发符合癌症患者需求、被认为有用并能有效改善用药依从性的数字干预措施,目前证据还很有限:本研究的目的是共同设计、开发并初步评估一种名为 "肿瘤用药安全与依从性及自我护理建议"(SAMSON)的创新型移动医疗解决方案,以改善癌症患者的用药依从性:利用设计科学研究方法的 4 个周期和 6 个过程,我们共同设计并开发了针对癌症患者的用药依从性解决方案。首先,我们对癌症患者的服药依从性进行了文献综述,并对当前解决这一问题的干预措施进行了系统性综述。行为科学研究被用于构思 SAMSON 的设计特点。其次,我们进行了两个设计阶段:原型设计和最终功能设计。最后,我们对血液肿瘤患者进行了为期6周的混合方法研究,以评估移动解决方案:开发的移动解决方案由移动应用程序、门户网站和云数据库组成,包括 5 个模块:用药提醒和确认、症状评估和管理、强化、患者档案和报告。定量研究(n=30)显示,SAMSON 易于使用(21/27,78%)。该应用程序引人入胜(18/27,67%),信息量大,增加了用户互动,组织良好(19/27,70%)。大多数参与者(21/27,78%)表示,SAMSON 的活动有助于提高他们对癌症治疗的依从性,超过半数的参与者(17/27,63%)会向同伴推荐该应用程序。定性研究(n=25)显示,SAMSON 在提醒、支持和告知患者方面很有帮助。使用 SAMSON 可能遇到的障碍包括应用程序故障和用户缺乏技术经验。此外,还发现了进一步完善解决方案的需求。技术改进和设计提升将纳入后续迭代中:本研究表明,行为科学研究和设计科学研究方法成功地应用于设计和开发移动解决方案,使癌症患者更加坚持治疗。该研究还强调了在开发有效的、以患者为中心的数字干预解决方案时应用严格方法的重要性。
{"title":"Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach.","authors":"Thu Ha Dang, Nilmini Wickramasinghe, Abdur Rahim Mohammad Forkan, Prem Prakash Jayaraman, Kate Burbury, Clare O'Callaghan, Ashley Whitechurch, Penelope Schofield","doi":"10.2196/46979","DOIUrl":"https://doi.org/10.2196/46979","url":null,"abstract":"<p><strong>Background: </strong>Medication nonadherence negatively impacts the health outcomes of people with cancer as well as health care costs. Digital technologies present opportunities to address this health issue. However, there is limited evidence on how to develop digital interventions that meet the needs of people with cancer, are perceived as useful, and are potentially effective in improving medication adherence.</p><p><strong>Objective: </strong>The objective of this study was to co-design, develop, and preliminarily evaluate an innovative mobile health solution called Safety and Adherence to Medication and Self-Care Advice in Oncology (SAMSON) to improve medication adherence among people with cancer.</p><p><strong>Methods: </strong>Using the 4 cycles and 6 processes of design science research methodology, we co-designed and developed a medication adherence solution for people with cancer. First, we conducted a literature review on medication adherence in cancer and a systematic review of current interventions to address this issue. Behavioral science research was used to conceptualize the design features of SAMSON. Second, we conducted 2 design phases: prototype design and final feature design. Last, we conducted a mixed methods study on patients with hematological cancer over 6 weeks to evaluate the mobile solution.</p><p><strong>Results: </strong>The developed mobile solution, consisting of a mobile app, a web portal, and a cloud-based database, includes 5 modules: medication reminder and acknowledgment, symptom assessment and management, reinforcement, patient profile, and reporting. The quantitative study (n=30) showed that SAMSON was easy to use (21/27, 78%). The app was engaging (18/27, 67%), informative, increased user interactions, and well organized (19/27, 70%). Most of the participants (21/27, 78%) commented that SAMSON's activities could help to improve their adherence to cancer treatments, and more than half of them (17/27, 63%) would recommend the app to their peers. The qualitative study (n=25) revealed that SAMSON was perceived as helpful in terms of reminding, supporting, and informing patients. Possible barriers to using SAMSON include the app glitches and users' technical inexperience. Further needs to refine the solution were also identified. Technical improvements and design enhancements will be incorporated into the subsequent iteration.</p><p><strong>Conclusions: </strong>This study demonstrates the successful application of behavioral science research and design science research methodology to design and develop a mobile solution for patients with cancer to be more adherent. The study also highlights the importance of applying rigorous methodologies in developing effective and patient-centered digital intervention solutions.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e46979"},"PeriodicalIF":2.8,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1